B Health and two safety-net hospitals want to help the government prove that drugmakers are required to give upfront ...

Shares of Johnson & Johnson fell over 2% on Wednesday, hitting nearly one-week lows, despite reporting better-than-expected fourth-quarter (Q4) earnings. The pharmaceutical giant posted Q4 adjusted ...

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for federal ...

J&J Chief Financial Officer Joe Wolk said on ... Editing by Stephen Coates and Nick Zieminski Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States.

J&J (JNJ) announced it planned to restructure its pharmaceutical division last year to focus on immunology, neuroscience and ...

J&J announced a definitive agreement to acquire Intra-Cellular Therapies for $132.00 per share or approximately $14.6 billion. The offer price represented a premium of almost 40% to ITCI’s ...

View all information regarding the medicines that are manufactured by J & J Chemicals & Pharmaceuticals including its generic drug name, trade name, how to use, the price, and its composition.

Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy treatment for major depressive disorder (MDD) in adults who do not respond to ...